Screening, imaging, AMR discovery policy
AMR screening facility HG2/3 https://warwick.ac.uk/fac/cross_fac/amrscreening/
Cross scale research capabilities from atomic to whole cell
https://warwick.ac.uk/fac/cross_fac/howard-dalton-centre/about/
Technology:
Microorganisms:
Application:
Development stage:
- Antimicrobial compound/strategy
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Fungi
- Parasites
- Viruses
- Yeasts
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Research
- Development
- Validation
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Academia
- Company
- Institute
- NGO
- Government
Partnering:
- License
- Co-develop
- Outsource
- Joint Venture
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- STI
- BSI
- RTI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
Academic, SME, global pharma
University
Leadership in Enhancing Antimicrobial Discovery (LEAD)
UK Japan collaboration a template for wider global consortia to train the next generation
https://warwick.ac.uk/newsandevents/pressreleases/?newsItem=8a1785d790977dd0019097dc97dc014b
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!